208 related articles for article (PubMed ID: 35551175)
1. UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer.
Xiang G; Wang S; Chen L; Song M; Song X; Wang H; Zhou P; Ma X; Yu J
Cell Death Dis; 2022 May; 13(5):451. PubMed ID: 35551175
[TBL] [Abstract][Full Text] [Related]
2. Targeting UBR5 inhibits postsurgical breast cancer lung metastases by inducing CDC73 and p53 mediated apoptosis.
Yu Z; Dong X; Song M; Xu A; He Q; Li H; Ouyang W; Chouchane L; Ma X
Int J Cancer; 2024 Feb; 154(4):723-737. PubMed ID: 37855385
[TBL] [Abstract][Full Text] [Related]
3. E3 Ubiquitin Ligase UBR5 Drives the Growth and Metastasis of Triple-Negative Breast Cancer.
Liao L; Song M; Li X; Tang L; Zhang T; Zhang L; Pan Y; Chouchane L; Ma X
Cancer Res; 2017 Apr; 77(8):2090-2101. PubMed ID: 28330927
[TBL] [Abstract][Full Text] [Related]
4. UBR5 promotes tumor immune evasion through enhancing IFN-γ-induced
Wu B; Song M; Dong Q; Xiang G; Li J; Ma X; Wei F
Theranostics; 2022; 12(11):5086-5102. PubMed ID: 35836797
[No Abstract] [Full Text] [Related]
5.
Qiao X; Liu Y; Prada ML; Mohan AK; Gupta A; Jaiswal A; Sharma M; Merisaari J; Haikala HM; Talvinen K; Yetukuri L; Pylvänäinen JW; Klefström J; Kronqvist P; Meinander A; Aittokallio T; Hietakangas V; Eilers M; Westermarck J
Cancer Res; 2020 Apr; 80(7):1414-1427. PubMed ID: 32029551
[TBL] [Abstract][Full Text] [Related]
6. UBR5 HECT domain mutations identified in mantle cell lymphoma control maturation of B cells.
Swenson SA; Gilbreath TJ; Vahle H; Hynes-Smith RW; Graham JH; Law HC; Amador C; Woods NT; Green MR; Buckley SM
Blood; 2020 Jul; 136(3):299-312. PubMed ID: 32325489
[TBL] [Abstract][Full Text] [Related]
7. The E3 ligase UBR5 regulates gastric cancer cell growth by destabilizing the tumor suppressor GKN1.
Yang M; Jiang N; Cao QW; Ma MQ; Sun Q
Biochem Biophys Res Commun; 2016 Sep; 478(4):1624-9. PubMed ID: 27590582
[TBL] [Abstract][Full Text] [Related]
8. Wnt-Dependent Inactivation of the Groucho/TLE Co-repressor by the HECT E3 Ubiquitin Ligase Hyd/UBR5.
Flack JE; Mieszczanek J; Novcic N; Bienz M
Mol Cell; 2017 Jul; 67(2):181-193.e5. PubMed ID: 28689657
[TBL] [Abstract][Full Text] [Related]
9. The tumor suppressor CDC73 interacts with the ring finger proteins RNF20 and RNF40 and is required for the maintenance of histone 2B monoubiquitination.
Hahn MA; Dickson KA; Jackson S; Clarkson A; Gill AJ; Marsh DJ
Hum Mol Genet; 2012 Feb; 21(3):559-68. PubMed ID: 22021426
[TBL] [Abstract][Full Text] [Related]
10. Downregulation of the proapoptotic protein MOAP-1 by the UBR5 ubiquitin ligase and its role in ovarian cancer resistance to cisplatin.
Matsuura K; Huang NJ; Cocce K; Zhang L; Kornbluth S
Oncogene; 2017 Mar; 36(12):1698-1706. PubMed ID: 27721409
[TBL] [Abstract][Full Text] [Related]
11. Cryo-EM structure of the chain-elongating E3 ubiquitin ligase UBR5.
Hodáková Z; Grishkovskaya I; Brunner HL; Bolhuis DL; Belačić K; Schleiffer A; Kotisch H; Brown NG; Haselbach D
EMBO J; 2023 Aug; 42(16):e113348. PubMed ID: 37409633
[TBL] [Abstract][Full Text] [Related]
12. UBR5 Contributes to Colorectal Cancer Progression by Destabilizing the Tumor Suppressor ECRG4.
Wang J; Zhao X; Jin L; Wu G; Yang Y
Dig Dis Sci; 2017 Oct; 62(10):2781-2789. PubMed ID: 28856538
[TBL] [Abstract][Full Text] [Related]
13. Identification of the HECT E3 ligase UBR5 as a regulator of MYC degradation using a CRISPR/Cas9 screen.
Schukur L; Zimmermann T; Niewoehner O; Kerr G; Gleim S; Bauer-Probst B; Knapp B; Galli GG; Liang X; Mendiola A; Reece-Hoyes J; Rapti M; Barbosa I; Reschke M; Radimerski T; Thoma CR
Sci Rep; 2020 Nov; 10(1):20044. PubMed ID: 33208877
[TBL] [Abstract][Full Text] [Related]
14. The MLLE domain of the ubiquitin ligase UBR5 binds to its catalytic domain to regulate substrate binding.
Muñoz-Escobar J; Matta-Camacho E; Kozlov G; Gehring K
J Biol Chem; 2015 Sep; 290(37):22841-50. PubMed ID: 26224628
[TBL] [Abstract][Full Text] [Related]
15. CircNR3C2 promotes HRD1-mediated tumor-suppressive effect via sponging miR-513a-3p in triple-negative breast cancer.
Fan Y; Wang J; Jin W; Sun Y; Xu Y; Wang Y; Liang X; Su D
Mol Cancer; 2021 Feb; 20(1):25. PubMed ID: 33530981
[TBL] [Abstract][Full Text] [Related]
16. Targeting ubiquitin protein ligase E3 component N-recognin 5 in cancer cells induces a CD8+ T cell mediated immune response.
Song M; Wang C; Wang H; Zhang T; Li J; Benezra R; Chouchane L; Sun YH; Cui XG; Ma X
Oncoimmunology; 2020; 9(1):1746148. PubMed ID: 32363114
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression of tumor suppressor CDC73, encoding an RNA polymerase II interactor, by Wilms tumor 1 protein (WT1) promotes cell proliferation: implication for cancer therapeutics.
Rather MI; Swamy S; Gopinath KS; Kumar A
J Biol Chem; 2014 Jan; 289(2):968-76. PubMed ID: 24257751
[TBL] [Abstract][Full Text] [Related]
18. UBR5 over-expression contributes to poor prognosis and tamoxifen resistance of ERa+ breast cancer by stabilizing β-catenin.
Yang Y; Zhao J; Mao Y; Lin G; Li F; Jiang Z
Breast Cancer Res Treat; 2020 Dec; 184(3):699-710. PubMed ID: 32914356
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-361-5p slows down gliomas development through regulating UBR5 to elevate ATMIN protein expression.
Jia J; Ouyang Z; Wang M; Ma W; Liu M; Zhang M; Yu M
Cell Death Dis; 2021 Jul; 12(8):746. PubMed ID: 34321465
[TBL] [Abstract][Full Text] [Related]
20. Modulation of myocardin function by the ubiquitin E3 ligase UBR5.
Hu G; Wang X; Saunders DN; Henderson M; Russell AJ; Herring BP; Zhou J
J Biol Chem; 2010 Apr; 285(16):11800-9. PubMed ID: 20167605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]